Managing Integrity in Deed by Clarity of Word

Pharmaceutical Compliance Monitor, Forthcoming

3 Pages Posted: 1 Oct 2013

See all articles by Craig B. Garner

Craig B. Garner

Pepperdine University - Rick J. Caruso School of Law; Garner Health Law Corporation

Date Written: July 17, 2013

Abstract

As the field of modern American healthcare continues to flex its newly grown muscles under the Affordable Care Act, the need for commitment to corporate integrity becomes ever more apparent. In a perfect world, the question of whether such leadership should come through an edict from the Federal Government or be provided as a matter of course within each individual company should not be a subject of debate, and yet recent failures on the part of of certain corporate giants within the health care community have forced the issue to the forefront, making those tasked with compliance ask the question “where does compliance begin?” The unnerving truth is that in today’s age of regulatory enforcement, the existence of an integrity agreement is little more than a necessary prerequisite, and its effectiveness suffers greatly as a result.

Suggested Citation

Garner, Craig B., Managing Integrity in Deed by Clarity of Word (July 17, 2013). Pharmaceutical Compliance Monitor, Forthcoming, Available at SSRN: https://ssrn.com/abstract=2333161

Craig B. Garner (Contact Author)

Pepperdine University - Rick J. Caruso School of Law ( email )

24255 Pacific Coast Highway
Malibu, CA 90263
United States
310-458-1560 (Phone)

HOME PAGE: http://www.garnerhealth.com

Garner Health Law Corporation ( email )

13274 Fiji Way
Suite 250
Marina del Rey, CA 90292
United States
310-458-1560 (Phone)

HOME PAGE: http://www.garnerhealth.com

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
21
Abstract Views
212
PlumX Metrics